title: Influence of pancreas transplantation alone on native renal function.
abstract: Pancreas transplantation alone (PTA) has become an accepted treatment of nonuremic diabetic patients, when the risks of secondary complications of diabetes mellitus are greater than those of the surgical procedure and the posttransplant immunosuppression. As a decrease in native renal function is expected, we followed this parameter among patients who underwent PTA. From January 1997 through January 2005, we performed 69 PTA in 66 patients. All patients showed glucose hyperlability with hypoglycemic unawareness, or two or more diabetic complications as well as creatinine clearance (CrCl) > or = 45 mL/min. Immunosuppression was based on tacrolimus, mycophenolate mofetil and prednisone. Twenty-four hour CrCl were performed after all successful PTA. We divided patients in two groups according to the pretransplant CrCl: group 1, CrCl < or = 70 mL/min (n = 20) and group 2, CrCl > 70 mL/min (n = 25). The data were analyzed using Student's t-test (P < or = .05 was considered significant). Twenty-one patients were excluded from the analysis because of death (n = 5) or graft loss (n = 8) during the first year or follow-up shorter than 1 year (n = 8). The mean value of CrCl decreased 28.8% (85.0 +/- 31 versus 60.5 +/- 36 mL/min; P < .001). There was also a 39.3% reduction among group 1 subjects (P = .003), including 10 who displayed CrCl < or = 30 mL/min. There was also a 24.4% reduction among group 2 (P = .008), but no patient developed end-stage renal disease. In conclusion, native renal function decreased significantly after PTA, but was well tolerated among patients with CrCl > 70 mL/min. Patients with CrCl < 70 mL/min show a significant risk of worsened renal function.
authors.affiliation: HEPATO-Hepatology and Organ Transplantation, Albert Einstein Hospital, São Paulo, Brazil.
authors.forename: T
authors.initials: T
authors.lastname: Genzini
authors.forename: G S
authors.initials: GS
authors.lastname: Marchini
authors.forename: A J B A
authors.initials: AJ
authors.lastname: Chang
authors.forename: I
authors.initials: I
authors.lastname: Antunes
authors.forename: A
authors.initials: A
authors.lastname: Hayashi
authors.forename: H
authors.initials: H
authors.lastname: Abensur
authors.forename: L
authors.initials: L
authors.lastname: Kataoka
authors.forename: F
authors.initials: F
authors.lastname: Crescentini
authors.forename: J Egídio
authors.initials: JE
authors.lastname: Romão
authors.forename: E B
authors.initials: EB
authors.lastname: Rangel
authors.forename: M
authors.initials: M
authors.lastname: Perosa
mesh_terms: D000328:Adult; D003404:Creatinine / Q000378:metabolism; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000502:physiology*; D016035:Pancreas Transplantation / Q000502:physiology*; D018579:Patient Selection; D006435:Renal Dialysis
chemical_list: D003404:Creatinine